MedPath

The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of Glioma

Conditions
Glioma
Interventions
Procedure: surgery
Registration Number
NCT04781764
Lead Sponsor
Huashan Hospital
Brief Summary

establishment of glioma microenvironment cell dynamic evolution database reveal the mechanism of GIM promoting malignant transformation of glioma cells reveal the dynamic regulation process of immune cells in the process of glioma evolution

Detailed Description

To collect tissue samples from different stages of glioma evolution and establish a high-quality high-throughput sequencing database of immune microenvironment cells, so as to lay a data foundation for later mining the dialogue mechanism and key targets between immune cells and tumor cells in glioma microenvironment.

Based on the analysis results of the above database, the key role of key target molecules in the dialogue between GIM and glioma cells and the regulation ability of immune cells in the immune microenvironment were confirmed through cell and mouse animal experiments, which laid the foundation for later targeted drug research and development.

Combined with fluorescence imaging technology, through in vivo imaging of mice, it can provide more intuitive and effective visual verification for the dynamic infiltration process of GIM and other immune microenvironment cells in the process of glioma evolution, and provide a new theoretical basis for the visualization research of dynamic regulation of glioma immune microenvironment cells.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The patients with glioma in the Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University who meet the following three conditions can be enrolled

    1. They were 18-80 years old, male and female;
    2. The pathological results of frozen section during operation were gliomas (20 cases of who grade II, II and IV, respectively);
    3. Tissue (6 mm * 6 mm) can be used for cell sorting on the basis of not affecting clinical routine diagnosis;
    4. Sign informed consent.
Exclusion Criteria
  • Patients who meet any of the following criteria will not be included in this study:

    1. Participants in other clinical trials;
    2. Pregnant women.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
glioma patientssurgeryglioma patients with routine surgery
Primary Outcome Measures
NameTimeMethod
Multi-omics characteristics of glioma patients24 month

we aim to describe patient's features about transcriptomics 、Immunomics、Radiomics ,etc.

expression level of protein,drived from paraffin-embedded specimens, retrospectively collected.24 month

different expression level of proteins in Gliomas with different grades and molecular subgroups (500 cases)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Huashan Hospital,Fudan University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath